NYSE:MCK - McKesson Stock Price Target and Predictions

Target and Analyst Ratings
Price Target History
Upgrades and Downgrades
About
FAQ

Consensus Rating: Buy
Consensus Price Target: $214.00
Forecasted Upside: 13.40 %
Number of Analysts: 10
Breakdown:
0 Sell Ratings
2 Hold Ratings
8 Buy Ratings
0 Strong Buy Ratings

^$188.72 As of 06/21/2021 01:00 AM ET

▲ +3.83 (2.07%)

1 month | 3 months | 12 months

Get New McKesson Analyst Ratings Delivered To Your Inbox

Sign-up to receive the latest news and ratings for MCK and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for MCK

^$214.00

▲ +13.40% Upside Potential

This price target is based on 10 analysts offering 12 month price targets for McKesson in the last 3 months. The average price target is $214.00, with a high forecast of $257.00 and a low forecast of $166.00. The average price target represents a 13.40% upside from the last price of $188.72.

Current Consensus is Buy

The current consensus among 10 polled investment analysts is to buy stock in McKesson. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details Read Past Recommendations Description Skip Past Price Target Consensus Chart

0 strong buy ratings
8 buy ratings
2 hold ratings
0 sell ratings

Ratings as of

12/29/2019

0 strong buy ratings
10 buy ratings
3 hold ratings
0 sell ratings

Ratings as of

3/28/2020

0 strong buy ratings
12 buy ratings
3 hold ratings
0 sell ratings

Ratings as of

6/26/2020

0 strong buy ratings
11 buy ratings
2 hold ratings
0 sell ratings

Ratings as of

9/24/2020

0 strong buy ratings
11 buy ratings
2 hold ratings
0 sell ratings

Ratings as of

12/23/2020

0 strong buy ratings
10 buy ratings
2 hold ratings
0 sell ratings

Ratings as of

3/23/2021

0 strong buy ratings
10 buy ratings
2 hold ratings
0 sell ratings

Ratings as of

5/22/2021

0 strong buy ratings
8 buy ratings
2 hold ratings
0 sell ratings

Ratings as of

6/21/2021

Latest Recommendations

Show Most Recent Rating from Each Ratings Firm Show All Ratings

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price
5/12/2021	Mizuho	Boost Price Target	Neutral	$190.00 ➝ $205.00	Low
5/10/2021	Credit Suisse Group	Boost Price Target	Neutral	$192.00 ➝ $222.00	Medium
5/7/2021	The Goldman Sachs Group	Boost Price Target	Buy	$231.00 ➝ $257.00	High
5/7/2021	Deutsche Bank Aktiengesellschaft	Boost Price Target	Buy	$231.00 ➝ $237.00	High
3/30/2021	Argus	Upgrade	Hold ➝ Buy	$230.00	Low
3/2/2021	Cowen	Boost Price Target	Positive ➝ Outperform	$210.00 ➝ $224.00	Low
2/3/2021	Morgan Stanley	Boost Price Target	Overweight	$219.00 ➝ $226.00	Low
2/3/2021	Credit Suisse Group	Boost Price Target	Neutral	$178.00 ➝ $192.00	Low
2/3/2021	Deutsche Bank Aktiengesellschaft	Boost Price Target	Buy	$222.00 ➝ $231.00	Low
2/3/2021	Mizuho	Boost Price Target	Neutral	$178.00 ➝ $190.00	Low
2/1/2021	Cowen	Boost Price Target	Outperform	$186.00 ➝ $210.00	Low
11/18/2020	The Goldman Sachs Group	Upgrade	Buy ➝ Conviction-Buy		Low
11/13/2020	Mizuho	Boost Price Target	Neutral	$150.00 ➝ $178.00	Medium
11/5/2020	Credit Suisse Group	Boost Price Target	Neutral	$174.00 ➝ $178.00	Medium
11/4/2020	Morgan Stanley	Boost Price Target	Overweight	$204.00 ➝ $219.00	High
11/4/2020	Deutsche Bank Aktiengesellschaft	Boost Price Target	Buy	$202.00 ➝ $222.00	High
11/2/2020	Barclays	Upgrade	Equal Weight ➝ Overweight	$166.00 ➝ $166.00	Medium
8/4/2020	JPMorgan Chase & Co.	Boost Price Target	Positive ➝ Overweight	$187.00 ➝ $198.00	Low
8/4/2020	Credit Suisse Group	Boost Price Target	Neutral	$160.00 ➝ $162.00	Low
8/4/2020	Morgan Stanley	Boost Price Target	Overweight	$194.00 ➝ $204.00	Medium
8/4/2020	Deutsche Bank Aktiengesellschaft	Upgrade	Hold ➝ Buy	$169.00 ➝ $202.00	Medium
7/8/2020	Guggenheim	Boost Price Target	Buy	$168.00 ➝ $175.00	Medium
6/15/2020	Morgan Stanley	Boost Price Target	Overweight	$163.00 ➝ $194.00	Medium
5/27/2020	Guggenheim	Boost Price Target	Buy	$147.00 ➝ $168.00	High
5/26/2020	UBS Group	Boost Price Target	Buy	$160.00 ➝ $165.00	Low
5/22/2020	Wolfe Research	Upgrade	Peer Perform ➝ Outperform	$184.00	Low
5/22/2020	Morgan Stanley	Boost Price Target	Overweight	$150.00 ➝ $163.00	Low
5/21/2020	Cowen	Boost Price Target	Outperform	$174.00 ➝ $186.00	Low
5/21/2020	Deutsche Bank Aktiengesellschaft	Lower Price Target	Hold	$173.00 ➝ $169.00	Low
5/21/2020	Mizuho	Boost Price Target	Neutral	$140.00 ➝ $147.00	Low
5/20/2020	Cfra	Lower Price Target	Buy	$179.00 ➝ $171.00	Medium
5/15/2020	UBS Group	Upgrade	Neutral ➝ Buy	$151.00 ➝ $160.00	High
4/22/2020	Credit Suisse Group	Initiated Coverage	Neutral	$146.00	Low
4/2/2020	Credit Suisse Group	Lower Price Target	Neutral	$155.00 ➝ $147.00	High
3/31/2020	Barclays	Lower Price Target	Equal Weight	$170.00 ➝ $163.00	Medium
3/27/2020	Morgan Stanley	Lower Price Target	Overweight	$182.00 ➝ $150.00	Low
3/18/2020	Credit Suisse Group	Reiterated Rating	Hold	$145.00	Medium
3/18/2020	JPMorgan Chase & Co.	Boost Price Target	Overweight	$186.00 ➝ $187.00	High
3/18/2020	The Goldman Sachs Group	Upgrade	Neutral ➝ Buy	$173.00 ➝ $174.00	High
3/13/2020	Guggenheim	Upgrade	Neutral ➝ Buy		Medium
3/6/2020	Morgan Stanley	Reiterated Rating	Buy	$182.00	Medium
2/11/2020	Morgan Stanley	Boost Price Target	Overweight	$168.00 ➝ $182.00	Medium
2/7/2020	Robert W. Baird	Upgrade	Neutral ➝ Outperform	$164.00 ➝ $197.00	Medium
2/5/2020	Robert W. Baird	Boost Price Target	Neutral	$161.00 ➝ $164.00	Medium
2/5/2020	Deutsche Bank Aktiengesellschaft	Boost Price Target	Hold	$153.00 ➝ $173.00	Medium
2/5/2020	Morgan Stanley	Boost Price Target	Overweight	$162.00 ➝ $168.00	Medium
1/19/2020	Barclays	Reiterated Rating	Hold	$170.00	Low
1/15/2020	Mizuho	Boost Price Target	Neutral	$137.00 ➝ $140.00	High
1/10/2020	Morgan Stanley	Upgrade	Equal Weight ➝ Overweight	$135.00 ➝ $162.00	Medium
1/9/2020	UBS Group	Downgrade	Sell	$147.00	High
9/12/2019	Deutsche Bank Aktiengesellschaft	Initiated Coverage	Hold	$155.00	Medium
9/5/2019	Cleveland Research	Reiterated Rating	Hold		Low
8/27/2019	Morgan Stanley	Boost Price Target	Equal Weight	$130.00 ➝ $135.00	High
8/5/2019	Wolfe Research	Downgrade	Outperform ➝ Peer Perform		Low
7/31/2019	Bank of America	Set Price Target	Buy	$160.00	N/A
7/22/2019	Credit Suisse Group	Initiated Coverage	Neutral	$143.00	Low
7/22/2019	Guggenheim	Initiated Coverage	Neutral ➝ Neutral	$152.00	Low
7/22/2019	JPMorgan Chase & Co.	Initiated Coverage	Overweight	$164.00	Low
4/2/2019	Wolfe Research	Initiated Coverage	Outperform		High
2/1/2019	Barclays	Reiterated Rating	Hold	$130.00	Medium
1/25/2019	Deutsche Bank Aktiengesellschaft	Upgrade	Sell ➝ Hold	$175.00	Low
1/17/2019	UBS Group	Initiated Coverage	Neutral ➝ Neutral	$134.00	Low
1/6/2019	Barclays	Reiterated Rating	Hold	$124.00	Low
12/9/2018	Morgan Stanley	Lower Price Target		$142.00 ➝ $130.00	Low
12/3/2018	Morgan Stanley	Lower Price Target	Equal Weight ➝ Equal Weight	$142.00 ➝ $130.00	Medium
10/26/2018	Barclays	Lower Price Target	Equal Weight ➝ Equal Weight	$150.00 ➝ $136.00	High
10/26/2018	Royal Bank of Canada	Set Price Target	Hold	$155.00	Medium
8/12/2018	Mizuho	Reiterated Rating	Hold	$133.00	High
7/27/2018	JPMorgan Chase & Co.	Lower Price Target	Overweight ➝ Overweight	$181.00 ➝ $160.00	Low
7/27/2018	Jefferies Financial Group	Reiterated Rating	Buy	$160.00	Medium
7/27/2018	Royal Bank of Canada	Reiterated Rating	Hold	$152.00	Medium
7/20/2018	Robert W. Baird	Downgrade	Outperform ➝ Neutral		Low
7/20/2018	Citigroup	Lower Price Target	Buy	$160.00 ➝ $2.86	Low
7/10/2018	Standpoint Research	Upgrade	Hold ➝ Buy		Low
7/3/2018	Morgan Stanley	Lower Price Target	Equal Weight ➝ Equal Weight	$175.00 ➝ $142.00	Low
6/29/2018	Royal Bank of Canada	Lower Price Target	Market Perform	$158.00	High
5/29/2018	SVB Leerink	Set Price Target	Market Perform ➝ Market Perform	$170.00 ➝ $160.00	High
4/11/2018	Bank of America	Lower Price Target	Buy ➝ Buy	$179.00 ➝ $172.00	Low
3/8/2018	Barclays	Initiated Coverage	Equal Weight ➝ Equal Weight	$165.00	Medium
2/27/2018	Bank of America	Initiated Coverage	Buy ➝ Buy	$179.00	Low
2/2/2018	Credit Suisse Group	Reiterated Rating	Sell	$130.00	High
2/2/2018	Mizuho	Lower Price Target	Neutral ➝ Neutral	$186.00 ➝ $179.00	High
1/24/2018	Mizuho	Set Price Target	Hold	$186.00	Low
1/24/2018	Jefferies Financial Group	Upgrade	Hold ➝ Buy	$205.00	High
1/23/2018	Needham & Company LLC	Boost Price Target	Buy ➝ Buy	$173.00 ➝ $180.00	Medium
1/17/2018	Robert W. Baird	Reiterated Rating	Buy	$200.00	Low
1/4/2018	Evercore ISI	Initiated Coverage	Outperform ➝ Outperform	$179.00	Low
12/4/2017	Deutsche Bank Aktiengesellschaft	Initiated Coverage	Buy	$175.00	High
11/9/2017	Credit Suisse Group	Reiterated Rating	Underperform	$155.00 ➝ $130.00	N/A
11/1/2017	Needham & Company LLC	Reiterated Rating	Buy ➝ Buy	$178.00 ➝ $173.00	N/A
10/27/2017	Royal Bank of Canada	Reiterated Rating	Hold	$170.00	N/A
10/24/2017	Mizuho	Set Price Target	Hold	$168.00	N/A
10/24/2017	Needham & Company LLC	Set Price Target	Buy	$179.00 ➝ $178.00	N/A
10/18/2017	Jefferies Financial Group	Set Price Target	Hold	$165.00	N/A
10/16/2017	Needham & Company LLC	Set Price Target	Buy	$179.00	N/A
10/10/2017	Cowen	Upgrade	Market Perform ➝ Outperform	$176.00 ➝ $189.00	N/A
9/19/2017	Royal Bank of Canada	Initiated Coverage	Sector Perform ➝ Sector Perform	$168.00	Low
9/19/2017	Robert W. Baird	Upgrade	Neutral ➝ Outperform	$175.00 ➝ $178.00	Low
9/14/2017	Morgan Stanley	Downgrade	Overweight ➝ Equal Weight	$184.00 ➝ $172.00	High
9/8/2017	Needham & Company LLC	Upgrade	Hold ➝ Buy	$179.00	Low
8/29/2017	Jefferies Financial Group	Set Price Target	Hold	$165.00	Low
7/27/2017	Jefferies Financial Group	Upgrade	Hold ➝ Buy	$153.00	Low
6/29/2017	SVB Leerink	Boost Price Target	Market Perform	$170.00	Medium
6/26/2017	UBS Group	Reiterated Rating	Neutral	$156.00 ➝ $166.00	N/A
6/4/2017	Barclays	Set Price Target	Buy	$187.00	Low
5/30/2017	Mizuho	Boost Price Target	Neutral ➝ Neutral	$147.00 ➝ $168.00	Low
5/25/2017	Morgan Stanley	Boost Price Target	Overweight	$165.00 ➝ $179.00	Low
5/23/2017	JPMorgan Chase & Co.	Upgrade	Neutral ➝ Overweight	$189.00	Medium
5/19/2017	SVB Leerink	Set Price Target	Hold	$140.00	High
5/19/2017	UBS Group	Boost Price Target	Neutral ➝ Neutral	$145.00 ➝ $156.00	N/A
5/17/2017	Jefferies Financial Group	Initiated Coverage	Hold ➝ Hold	$153.00	Medium
4/27/2017	Barclays	Reiterated Rating	Overweight	$174.00	Low
4/21/2017	SVB Leerink	Reiterated Rating	Hold	$140.00	Low
4/17/2017	Evercore ISI	Reiterated Rating	Outperform	$166.00	Low
4/4/2017	Needham & Company LLC	Initiated Coverage	Hold		Low
3/6/2017	Citigroup	Boost Price Target	Buy	$169.00 ➝ $175.00	N/A
3/3/2017	Credit Suisse Group	Reiterated Rating	Sell		N/A
1/21/2017	SVB Leerink	Set Price Target	Hold	$155.00	N/A
1/18/2017	Avondale Partners	Upgrade	Market Perform ➝ Outperform	$157.00 ➝ $193.00	N/A
1/5/2017	JPMorgan Chase & Co.	Downgrade	Overweight ➝ Neutral	$171.00 ➝ $169.00	N/A
1/3/2017	Mizuho	Downgrade	Buy ➝ Neutral	$147.00	N/A
11/23/2016	Credit Suisse Group	Downgrade	Neutral ➝ Underperform	$150.00 ➝ $131.00	N/A
11/11/2016	Standpoint Research	Downgrade	Buy ➝ Hold		N/A
11/9/2016	Mizuho	Upgrade	Neutral ➝ Buy	$147.00	N/A
10/28/2016	Standpoint Research	Upgrade	Hold ➝ Buy	$156.00	N/A
10/28/2016	Deutsche Bank Aktiengesellschaft	Downgrade	Buy ➝ Hold	$196.00 ➝ $153.00	N/A
10/28/2016	SVB Leerink	Downgrade	Outperform ➝ Market Perform		N/A
10/28/2016	Robert W. Baird	Downgrade	Outperform ➝ Neutral	$200.00 ➝ $164.00	N/A
10/5/2016	UBS Group	Initiated Coverage	Neutral	$182.00	N/A
9/26/2016	Mizuho	Lower Price Target	Neutral	$197.00 ➝ $183.00	N/A
9/19/2016	Argus	Reiterated Rating	Hold		N/A
9/16/2016	The Goldman Sachs Group	Downgrade	Buy ➝ Neutral	$210.00 ➝ $189.00	N/A
9/1/2016	SVB Leerink	Reiterated Rating	Outperform	$230.00	N/A
8/11/2016	Mizuho	Boost Price Target	Neutral	$174.00 ➝ $197.00	N/A
8/9/2016	JPMorgan Chase & Co.	Boost Price Target	Overweight	$210.00 ➝ $221.00	N/A
7/28/2016	Morgan Stanley	Boost Price Target	Overweight	$199.00 ➝ $211.00	N/A
7/28/2016	Citigroup	Boost Price Target	Buy	$215.00 ➝ $225.00	N/A
7/18/2016	Deutsche Bank Aktiengesellschaft	Reiterated Rating	Buy		N/A
7/6/2016	Avondale Partners	Reiterated Rating	Market Perform	$172.00 ➝ $197.00	N/A
6/30/2016	JPMorgan Chase & Co.	Reiterated Rating	Buy		N/A
6/30/2016	Bank of America	Reiterated Rating	Hold		N/A
6/29/2016	Robert W. Baird	Reiterated Rating	Buy	$220.00	N/A
6/29/2016	(FBRC)	Reiterated Rating	Buy	$210.00	N/A
6/22/2016	(FBRC)	Reiterated Rating	Buy		N/A

(Data available from 6/21/2016 forward)

McKesson Corporation provides healthcare supply chain management, retail pharmacy, community oncology and specialty care, and healthcare information solutions in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The International segment offers distribution and services to wholesale, institutional, and retail customers in 13 European countries and Canada. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The RxTS segment offers CoverMyMeds solution to help patients get the medications; RelayHealth, a workflow solution; RxCrossroads solution for therapies and interventions to biopharma manufacturers; and McKesson Prescription Automation, a customized pharmacy automation technology; and Multi-Client Central Fill as a Service, a pharmacy. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.

Today's Range

Now: $188.72

$185.32

$189.22

50 Day Range

MA: $193.70

$184.89

$202.68

52 Week Range

Now: $188.72

$139.76

$204.66

Volume

1,145,384 shs

Average Volume

1,069,008 shs

Market Capitalization

$29.85 billion

P/E Ratio

N/A

Dividend Yield

0.91%

Beta

0.88

Frequently Asked Questions

What sell-side analysts currently cover shares of McKesson?

The following Wall Street analysts have issued stock ratings on McKesson in the last twelve months: Argus, Barclays PLC, Cowen Inc, Credit Suisse Group AG, Deutsche Bank Aktiengesellschaft, Guggenheim, JPMorgan Chase & Co., Mizuho, Morgan Stanley, The Goldman Sachs Group, Inc., TheStreet, and Zacks Investment Research.
View the latest analyst ratings for MCK.

What is the current price target for McKesson?

10 Wall Street analysts have set twelve-month price targets for McKesson in the last year. Their average twelve-month price target is $214.00, suggesting a possible upside of 15.7%. The Goldman Sachs Group, Inc. has the highest price target set, predicting MCK will reach $257.00 in the next twelve months. Barclays PLC has the lowest price target set, forecasting a price of $166.00 for McKesson in the next year.
View the latest price targets for MCK.

What is the current consensus analyst rating for McKesson?

McKesson currently has 2 hold ratings and 8 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe MCK will outperform the market and that investors should add to their positions of McKesson.
View the latest ratings for MCK.

What other companies compete with McKesson?

Other companies that are similar to McKesson include AmerisourceBergen, Cardinal Health, Henry Schein, Patterson Companies and Owens & Minor.

How do I contact McKesson's investor relations team?

McKesson's physical mailing address is 6555 STATE HWY 161, IRVING TX, 75039. The company's listed phone number is 972-446-4800 and its investor relations email address is [email protected] The official website for McKesson is www.mckesson.com.